hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cell Reports Medicine

Topics

Biology

Biochemistry

Medicine

Immunology

Internal Medicine

Show all topics

DOI

10.1016/j.xcrm.2022.100717

License

CC-BY

Other Formats

PDF